63019-98-7

Usage

Chemical Properties

Off-White Crystals

InChI:InChI=1/C13H13N/c1-10-9-12(7-8-13(10)14)11-5-3-2-4-6-11/h2-9H,14H2,1H3

Upstream product

• 69314-47-2 3-methyl-4-nitrobiphenyl 
• 63040-30-2 N-(3-methyl-biphenyl-4-yl)-acetamide 
• 5152-76-1 N-chloro-2'-methylacetanilide 
• 71-43-2 benzene 
• 583-75-5 4-Bromo-2-methylaniline 
• 643-93-6 3-methylbiphenyl 
• 51366-39-3 4-acetamido-2-methylnitrobenzene 
• 98-80-6 phenylboronic acid 
• 13194-68-8 4-iodo-2-methylaniline 
• 24388-23-6 2-phenyl-4,4,5,5-tetramethyl-1,3,2-dioxoborole 
• 780-69-8 triethoxyphenylsilane 
• 95-69-2 4-chloro-2-methylbenzeneamine 
• 120-66-1 N-(2-methylphenyl)acetamide 
• 24106-05-6 4'-bromo-2'-methylacetanilide 

Downstream Products

• 63040-30-2 N-(3-methyl-biphenyl-4-yl)-acetamide 
• 92022-07-6 1-bromo-2-methyl-4-phenylbenzene 
• 113431-50-8 8-methyl-6-phenylquinoline 
• 672960-80-4 tert-butyl [1-(4-phenyl-2-toluidinylcarbamoyl)-1-phenyl-methyl]-carbamate 
• 3419-49-6 4-amino-3-methylbiphenyl hydrochloride 
• 1383382-33-9 C₄₇H₄₆N₂ 
• 113431-40-6 6-Phenyl-quinoline-8-carboxylic acid (2-dimethylamino-ethyl)-amide; hydrochloride 

Relevant academic research and scientific papers

A new Pd(II)-supported catalyst on magnetic SBA-15 for C-C bond formation via the Heck and Hiyama cross-coupling reactions

Magnetic mesoporous silica composite (MNP@SiO2-SBA) was obtained via embedding magnetite nanoparticles between SBA-15 channels. It was silylated with N-(3-(trimethoxysilyl)propyl)picolinamide (TMS-PCA) and then complexed with Pd(II). The obtained supported Pd(II) catalyst (MNP@SiO2-SBA-PCA) was characterized by conventional methods. The prepared magnetic catalyst showed high activity in the Heck and Hiyama reactions under optimal reaction conditions, including solvent, amount of catalyst, base, and temperature. Aryl bromides and iodides showed better results than aryl chlorides, and the catalyst exhibited noticeable stability and reused several times.

METAL COMPLEX, COMPOSITION AND LIGHT EMITTING DEVICE

A metal complex represented by formula (1) is provided. In formula (1), X represents a nitrogen atom or a group represented by ═C(RX)—; R1 represents an alkyl group having 4 or more carbon atoms; R2 represents an alkyl, cycloalkyl, alkoxy, cycloalkoxy, aryl, aryloxy, monovalent heterocyclic, or substituted amino group or a halogen atom; rings A and B each independently represent an aromatic hydrocarbon ring or an aromatic heterocyclic ring; M represents a rhodium, palladium, iridium, or platinum atom; n1 represents an integer of 1 or more, n2 represents an integer of 0 or more, and n1+n2 is 2 or 3; A1-G1-A2 represents an anionic bidentate ligand; A1 and A2 each independently represent a carbon atom, an oxygen atom, or a nitrogen atom; and G1 represents a single bond or an atomic group constituting a bidentate ligand together with A1 and A2.

Novel 5-methyl-2-phenylphenanthridium derivatives as FtsZ-targeting antibacterial agents from structural simplification of natural product sanguinarine

A novel series of 5-methyl-2-phenylphenanthridium derivatives were displayed outstanding activity against a panel of antibiotic-sensitive and -resistant bacteria strains compared with their precursor sanguinarine, ciprofloxacin and oxacillin sodium. Compounds 7 l, 7m and 7n were found to display the most effective activity against five sensitive strains (0.06–2 μg/mL) and three resistant strains (0.25–4 μg/mL). The kinetic profiles indicated that compound 7l possessed the strongest bactericidal effect on S. aureus ATCC25923, with the MBC value of 16 μg/mL. The cell morphology and the FtsZ polymerization assays indicated that these compounds inhibited the bacterial proliferation by interfering the function of bacterial FtsZ. The SARs showed that all the 4-methyl-substituted 5-methyl-2-phenylphenanthridium subseries could be further investigated as the FtsZ-targeting antibacterial agents.

PRODUCTION METHOD OF 1, 2, 4-TRIAZOLE COMPOUND

A method for producing a 1,2,4-triazole compound involves reacting an amide compound represented by formula (2) with a hydrazide compound represented by formula (3) in a solvent in the presence of a Lewis acid and a Lewis base, thereby obtaining a 1,2,4-triazole compound represented by formula (1): R1 represents an alkyl group, a cycloalkyl group, an alkoxy group, a cycloalkoxy group, an aryl group, an aryloxy group, a monovalent heterocyclic group or a substituted amino group, R2 and R3 each independently represent a hydrogen atom, an alkyl group, a cycloalkyl group, an aryl group, a monovalent heterocyclic group or a substituted amino group, and Ring A and Ring B each independently represent an aromatic hydrocarbon ring or an aromatic heterocyclic ring.

Palladium-Catalyzed Suzuki Reactions in Water with No Added Ligand: Effects of Reaction Scale, Temperature, pH of Aqueous Phase, and Substrate Structure

The heterogeneous palladium-catalyzed Suzuki reactions between model aryl bromides (4-bromoanisole, 4-bromoaniline, 4-amino-2-bromopyridine, and 2-bromopyridine) and phenylboronic acid have been successfully conducted in water with no added ligand at the 100 mL scale using 20-40 mmol of aryl bromide. The product yields associated with these substrates were optimized, and key reaction parameters affecting the yields were identified. The results clearly indicate that the reaction parameters necessary to achieve high yields are substrate-dependent. In addition, it is demonstrated that aqueous Suzuki reactions of substrates containing basic nitrogen centers can produce quantitative yields of desired products in the absence of added ligand.

WNT PATHWAY MODULATORS

The present invention relates to dihydropyrazolo[l,5-a]pyrimidine compounds of formula I, defined herein, as WNT pathways modulators, processes for making them, and pharmaceutical compositions comprising them. Methods of treatment of conditions mediated by WNT pathway signalling including cancer, fibrosis, stem cell and diabetic retinopathy, rheumatoid arthritis, psoriasis and myocardial infarction, comprising the compounds of formula I are also provided.

Structure-activity relationship study of E6 as a novel necroptosis inducer

Necroptosis inducers represent a promising potential treatment for drug-resistant cancer. We herein describe the structure modification of E6, which was identified recently as a potent and selective necroptosis inducer. The studies described herein demonstrate for the first time that functionalized biphenyl derivatives possess necroptosis inducer activity. Furthermore, these studies have led to the identification of two promising compounds (5h and 5j) that can be used for further optimization studies as well as mechanism of action investigations.

Room-temperature Suzuki-Miyaura cross-coupling reaction with α-diimine Pd(II) catalysts

An α-diimine Pd(II) complex containing chiral sec-phenethyl groups, {bis[N,N′-(4-methyl-2-sec-phenethylphenyl)imino]-2,3-butadiene}dichloropalladium (rac-C1), was synthesized and characterized. rac-C1 was applied as an efficient catalyst for the Suzuki-Miyaura cross-coupling reaction between various aniline halides and arylboronic acid in PEG-400-H2O at room temperature. Among a series of aniline halides, rac-C1 did not catalyze the cross-coupling of aniline chlorides and fluorides but efficiently catalyzed the cross-coupling of aniline bromides and iodides with phenylboronic acid. The catalytic activity reduced slightly with increasing steric hindrance of the aniline bromides. The complexes {bis[N,N′-(4-fluoro-2,6-diphenylphenyl)imino]-2,3-butadiene}dichloropalladium and {bis[N,N′-(4-fluoro-2,6-diphenylphenyl)imino]acenaphthene}dichloropalladium were also found to be efficient catalysts for the reaction.

METAL COMPLEXES, COMPRISING CARBENE LIGANDS HAVING AN O-SUBSTITUTED NON-CYCLOMETALATED ARYL GROUP AND THEIR USE IN ORGANIC LIGHT EMITTING DIODES

Cyclometallated Ir complex comprising three N,N diaryl substituted carbene ligands, bearing substituents in the 2 position of the non-cyclometallated aryl ring;an organic electronic device, preferably an organic light-emitting diode (OLED), comprising at least one cyclometallated Ir complexas described above, a light-emitting layer comprising said cyclometallated Ir complex preferably as emitter material, preferably in combination with at least one host material, use of said cyclometallated Ir complex in an OLED and an apparatus selected from the group consisting of stationary visual display units, mobile visualdisplay units, illumination units, units in items of clothing, units in handbags, units in accessoires, units in furniture and units in wallpaper comprising said organic electronic device, preferably said OLED, or said light-emitting layer. The present invention further relates to a process for the preparation of said cyclometallated Ir complex.

Pd-aminoclay nanocomposite as an efficient recyclable catalyst for hydrogenation and suzuki cross coupling reactions

A highly water dispersible Pd-aminoclay nanocomposite is found to be effective catalytic system for the hydrogenation of α,β-unsaturated carbonyl compounds and Suzuki coupling reactions in aqueous media. The catalytic hydrogenation of α,β-unsaturated carbonyl compounds proceeds at room temperature to afford the corresponding products in excellent yields with high chemoselectivity. The cross coupling of aryl bromides and iodides with aryl boronic acids proceeds efficiently under aqueous conditions at 90 °C to afford the corresponding biaryls in excellent yields with high selectivity. The Suzuki reaction proceeds smoothly even in the absence of external base due to the basic nature of the catalyst support. The catalyst could be easily recovered and recycled three times without a significant loss of activity in hydrogenation and Suzuki cross coupling reactions. Copyright